衛材在華企(qi)業隸屬(shu)于衛材株式會社,衛材株式會社是一家以研究開發醫藥產(chan)品為主的跨國公司,總部設在日本(ben)東京。
衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)中(zhong)(zhong)(zhong)國(guo)自上(shang)世紀90年(nian)(nian)代初進入(ru)中(zhong)(zhong)(zhong)國(guo)市場以來順利(li)發(fa)展壯大。自1991年(nian)(nian)先(xian)后(hou)成(cheng)立(li)沈陽衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)和衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(蘇(su)州)制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si),并于(yu)(yu)2002年(nian)(nian)正(zheng)式更名為衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(中(zhong)(zhong)(zhong)國(guo))藥(yao)(yao)(yao)業(ye)(ye)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)。伴隨著中(zhong)(zhong)(zhong)國(guo)業(ye)(ye)務的發(fa)展,于(yu)(yu)2010年(nian)(nian)成(cheng)立(li)衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(蘇(su)州)貿(mao)易有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si),于(yu)(yu)2014年(nian)(nian)成(cheng)立(li)衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(中(zhong)(zhong)(zhong)國(guo))投資(zi)(zi)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si),并于(yu)(yu)2015年(nian)(nian)通(tong)過全額收購本地(di)仿制(zhi)(zhi)藥(yao)(yao)(yao)企業(ye)(ye)正(zheng)式成(cheng)立(li)衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(遼寧)制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)。至此,形成(cheng)了以衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(中(zhong)(zhong)(zhong)國(guo))投資(zi)(zi)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)為資(zi)(zi)控管理,以衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(中(zhong)(zhong)(zhong)國(guo))藥(yao)(yao)(yao)業(ye)(ye)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)、衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(遼寧)制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)、衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(蘇(su)州)貿(mao)易有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)為業(ye)(ye)務支撐的發(fa)展模式。為適(shi)應(ying)中(zhong)(zhong)(zhong)國(guo)業(ye)(ye)務的迅速發(fa)展,2014年(nian)(nian)11月衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)(中(zhong)(zhong)(zhong)國(guo))藥(yao)(yao)(yao)業(ye)(ye)有(you)(you)(you)(you)限(xian)公(gong)司(si)(si)(si)(si)注射劑工廠(chang)(chang)竣(jun)工, 2017年(nian)(nian)11月新固體(ti)制(zhi)(zhi)劑廠(chang)(chang)房落成(cheng),衛(wei)(wei)(wei)(wei)(wei)材(cai)(cai)中(zhong)(zhong)(zhong)國(guo)的產能(neng)得(de)到迅速提(ti)升。
目前,總注冊資本10,854萬美金(jin)。已形成以神經科學(xue)領域(yu)、腫瘤(特藥)領域(yu)、消化肝病領域(yu)為主要領域(yu),拓展仿制藥領域(yu),多達(da)數十種藥品在中國銷售的發展規模(mo)。
未來,蘇州(zhou)工廠(chang)除滿(man)足(zu)中國(guo)患者臨床用藥的(de)需(xu)求外,將(jiang)向亞(ya)洲(zhou)其(qi)它國(guo)家和地區同樣提供高(gao)品質滿(man)足(zu)患者需(xu)求的(de)產品。